skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of obtaining active antisense compounds

Patent ·
OSTI ID:1531738

Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.

Research Organization:
Isis Phramaceuticals, Inc., Carlsbad, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG03-99ER62732
Assignee:
Isis Pharmaceuticals, Inc. (Carlsbad, CA)
Patent Number(s):
8,202,982
Application Number:
12/557,358
OSTI ID:
1531738
Resource Relation:
Patent File Date: 2009-09-10
Country of Publication:
United States
Language:
English

References (18)

Kinetics of G-Quartet-Mediated Tetramer Formation journal January 1996
Antisense oligonucleotides to human serine/threonine protein phosphatase genes patent September 1999
Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences patent May 2000
Antisense oligonucleotides against human protein kinase C patent March 1999
Phosphorothioate oligonucleotides that bind to the V3-loop and uses thereof patent May 1998
RNase L activators and antisense oligonucleotides effective to treat RSV infections patent April 2001
Human VEGF-specific oligonucleotides patent August 1997
Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices journal January 1992
Bias in Nucleotide Composition of Antisense Oligonucleotides journal January 1996
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability journal November 1999
Inhibitors of human immunodeficiency virus patent June 1996
Predicting oligonucleotide affinity to nucleic acid targets journal November 1999
Oligonucleotides Containing the G-Quartet Sequence Motif book January 1999
Oligonucleotides having a conserved G4 core sequence patent September 1999
Antisense oligonucleotide modulation of multidrug resistance-associated protein patent September 1998
Tetranucleotide GGGA Motif in Primary RNA Transcripts: NOVEL TARGET SITE FOR ANTISENSE DESIGN journal September 1998
Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides journal February 1996
Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. journal February 1994

Similar Records

Methods of obtaining active antisense compounds
Patent · Tue Sep 22 00:00:00 EDT 2009 · OSTI ID:1531738

Leukemic cell killing by samarium-153 labeled antisense oligodeoxynucleotide probes
Journal Article · Sun May 01 00:00:00 EDT 1994 · Journal of Nuclear Medicine · OSTI ID:1531738

Antisense oligodeoxynucleotide inhibition as a potent diagnostic tool for gene function in plant biology
Journal Article · Tue Jan 15 00:00:00 EST 2008 · Plant Signaling and Behavior · OSTI ID:1531738

Related Subjects